ALGS
#4590
Aligos Therapeutics, Inc. - Common stock
6.3 6 USD
-0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.93%
Monthly Change
+20.00%
6 month change
-29.49%
Year Change
-35.04%
Previous Close
6.6 2
Open
6.3 6
Low
6.3 6
High
6.3 6
Volume
4
Financials
- Market Capitalization 22.03 M
- Employee 82
- Founded 2018
- CEO N/A
- Website www.aligos.com
- Headquarter Delaware, United States
- FIGI BBG00QX7QH68
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.8
Price to sales ratio
21
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4559 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.73 USD | 0.00% | +5.80% | -2.67% | -63.50% | 23.77 M USD | ||
| 4570 |  SKYE Skye Bioscience, Inc. - Common Stock | 0.66 USD | -4.35% | -5.71% | -16.46% | -17.50% | 23.19 M USD | ||
| 4591 |  VYNE VYNE Therapeutics Inc. - Common Stock | 0.66 USD | +3.13% | 0.00% | +1.54% | -50.00% | 22.01 M USD | ||
| 4592 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.59 USD | +0.22% | +3.90% | -6.66% | +132.31% | 22.00 M USD |
Frequently asked questions about Aligos Therapeutics, Inc. - Common stock
What is the Aligos Therapeutics, Inc. - Common stock stock price today?
The current price of Aligos Therapeutics, Inc. - Common stock (ALGS) is 6.36. Over the past 24 hours, the stock has changed by -3.93%. Follow the ALGS chart for real-time price dynamics.
What is the stock ticker of Aligos Therapeutics, Inc. - Common stock?
Aligos Therapeutics, Inc. - Common stock trades under the ticker ALGS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aligos Therapeutics, Inc. - Common stock stock going up?
ALGS has changed by +7.61% over the last week, +20.00% over the last month, and -35.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Aligos Therapeutics, Inc. - Common stock net income for the last quarter?
Aligos Therapeutics, Inc. - Common stock reported net income of -23.04 M for the last quarter. The previous quarter showed -19.88 M, which means net income changed by -15.89%.
How many employees does Aligos Therapeutics, Inc. - Common stock have?
As of the latest available data, Aligos Therapeutics, Inc. - Common stock has 82 employees. Workforce size can provide additional context about the company's scale and operations.
What is Aligos Therapeutics, Inc. - Common stock EBITDA?
Aligos Therapeutics, Inc. - Common stock EBITDA is -26.9 M, and its EBITDA margin is -918.16%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aligos Therapeutics, Inc. - Common stock stock?
You can buy Aligos Therapeutics, Inc. - Common stock (ALGS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aligos Therapeutics, Inc. - Common stock stock?
Investing in Aligos Therapeutics, Inc. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALGS chart and related analysis on metatrader.com as part of your research.